Dose dense, high intensity therapy for mantle cell lymphoma.

被引：0
|
作者：
Rizzieri, DA
Gockerman, JP
Moore, JO
DeCastro, C
Long, GD
Vredenburgh, JJ
Niedzwiecki, D
Edwards, J
Prosnitz, L
Gasparetto, C
Morris, A
Lassiter, M
Davis, P
Chao, NJ
机构：
[1] Duke Univ, Med Ctr, Div Oncol & Stem Cell Transplantat, Durham, NC 27706 USA
[2] Walt Disney Canc Ctr, Duke Oncol Consortium, Orlando, FL USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2851
引用
收藏
页码：681A / 682A
页数：2
相关论文
共 50 条
  • [1] Multimodal dose dense therapy for mantle cell lymphoma.
    Wanko, SO
    Gocherman, JP
    Moore, JO
    Decastro, C
    Prosnitz, R
    Gasparetto, C
    Chute, J
    Horowitz, M
    Ashley, M
    Emily, E
    Patty, D
    Nelson, CJ
    Rizzieri, DA
    BLOOD, 2004, 104 (11) : 329A - 330A
  • [2] Multimodal dose dense therapy for mantle cell lymphoma.
    Wanko, SO
    Gockerman, JP
    Moore, JO
    de Castro, C
    Diehl, L
    Pronitz, R
    Gasparetto, C
    Chute, J
    Horwitz, M
    Morris, A
    Ali-Osman, F
    Rao, A
    Niedzweicki, D
    Long, GD
    Chao, NJ
    Rizzieri, DA
    BLOOD, 2005, 106 (11) : 463B - 463B
  • [3] Mantle cell lymphoma.
    Densmore J.J.
    Williams M.E.
    Current Treatment Options in Oncology, 2000, 1 (3) : 281 - 285
  • [4] Dose dense, high intensity induction therapy followed by early high dose chemotherapy (HDT) and autologous hematopoietic stem cell transplantation (AHSCT) for mantle cell lymphoma (MCL).
    Koh, LP
    Gockerman, JP
    Moore, JO
    DeCastro, C
    Long, GD
    Gasparetto, C
    Niedzwiecki, D
    Edwards, J
    Prosnitz, L
    Horwitz, M
    Chute, J
    Morris, A
    Lassiter, M
    Loftis, J
    Davis, P
    Chao, NJ
    Rizzieri, DA
    BLOOD, 2004, 104 (11) : 261A - 261A
  • [5] Current strategies in mantle cell lymphoma. Conventional therapy
    Dreyling, M
    ANNALS OF ONCOLOGY, 2005, 16 : 48 - 48
  • [6] Rituximab/chemotherapy induction treatment followed by high-dose therapy and autologous transplantation in patients with mantle cell lymphoma.
    Thieblemont, C
    Antal, D
    Lacotte-Thierry, L
    Delwail, V
    Bouafia, F
    Tartas, S
    Michallet, AS
    Espinouse, D
    Giraud, C
    Salles, G
    Guilhot, F
    Coiffier, B
    BLOOD, 2004, 104 (11) : 390A - 390A
  • [7] Dendritic cell-based therapy for the treatment of mantle cell lymphoma.
    Munger, CM
    Hentzen, A
    Vose, JM
    Bociek, RG
    Joshi, SS
    BLOOD, 2003, 102 (11) : 106A - 106A
  • [8] High dose therapy and autologous stem cell transplantation in mantle cell lymphoma
    Hiddemann, W
    Dreyling, M
    Parwaresch, R
    Unterhalt, M
    ANNALS OF ONCOLOGY, 2005, 16 : 48 - 49
  • [9] Complete clinical response with single-agent high dose Rituximab in mantle cell lymphoma.
    Jain, D
    Dutcher, JP
    Wiernik, PH
    BLOOD, 2003, 102 (11) : 305B - 305B
  • [10] High-dose therapy for mantle cell lymphoma - the Nottingham experience
    Jones, SG
    Gilyead, M
    Russell, NH
    Haynes, AP
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 37 - 37
12345